Indications

It is used to prevent hepatitis B infection. 

Highlights

1. Safer, without thiocyanate treatment

2. Adopts HBsAg  Subtype adr, which is predominated in Asia and pacific region

3. Full glycosylation,  high stability

4. Groups of all age

5. Immunization response is induced at the 8th day after the vaccination

6. 85.76% of immunization efficacy at the 8th year after vaccination

Specification

Pediatrics: 0.5ml:10μg of HBsAg/dose 

Adults：   1.0ml: 20μg of HBsAg/dose

Dosage Form

liquid for Injection

Route of Administration

Intramuscular injection

Shelf life 

36 months